The personalized treatment plan recommendations developed by Dr. LaValley are drawn directly from the scientific evidence base accessed through PubMed and PubMed Central®.

“PubMed is a free resource that is developed and maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine® (NLM®), located at the National Institutes of Health (NIH).”

The PubMed database contains over 25 million scientific references and citations which are richly indexed and connected by advanced search algorithms. These 25+ million citations of biomedical literature from MEDLINE®, life science journals, and online books include the fields of biomedicine, health, life sciences, behavioral sciences, chemical sciences, and bioengineering.

PubMed also provides access to additional relevant web sites and links to the other NCBI molecular biology resources. PubMed is also sometimes referred to as MEDLINE® and vice-versa. While there are differences between the two that are important to experts, the two terms are frequently used interchangeably with the most common being the term ‘PubMed.’

PubMed provides quality control in scientific publishing. Only journals that meet PubMed’s scientific standards are indexed. The database is maintained and updated by the National Library of Medicine® on a weekly basis.

The U.S. National Library of Medicine® (NLM®) provides the the worlds largest online biomedical library. Under the auspices of the NLM®, the National Center for Biotechnology Information (NCBI) maintains a large collection of scientific and biomedical databases.

PubMed Central® (PMC) is a free full-text archive of biomedical and life sciences journal literature containing over 3.6 million scientific articles which are free for any user to read, download and store for reference.

This wealth of scholarly knowledge is of significant importance for researchers in making scientific discoveries and healthcare professionals in managing health-related matters.

Dr. LaValley has devoted himself to developing methodologies for understanding, search, retrieval, utilization, and practical administration of the evidence-based molecularly-targeted data regarding natural product supplements and re-purposed anti-cancer ‘off-label’ pharmaceuticals within PubMed and PubMed Central®.